Shares to slip after Wall St fell amid latest Trump tariff threats. Resmed beats in fourth quarter earnings. Downer secures ...

Shares to slip after Wall St fell following a new round of Trump tariff threats. Resmed beats in fourth quarter earnings.

Pharmaceutical CEOs are on notice about sky-high drug prices as President Donald Trump demands a recalibration of what Americans are paying compared to other countries.

President Trump on Thursday sent letters to 17 of the world’s biggest drugmakers demanding that they reduce some of their U.S. prices to the much lower levels they charge other wealthy countries by ...

Tempus AI's 10% dip reveals an opportunity as Q2 estimates are poised to exceed expectations, fueled by strong deals and ...

President Donald Trump sent letters to 17 leading pharmaceutical manufacturers, including Eli Lilly (NYSE:LLY), Pfizer ...

Ionis Pharmaceuticals IONS reported second-quarter 2025 adjusted earnings per share (EPS) of 86 cents, significantly beating the Zacks Consensus Estimate of 27 cents. In the year-ago period, the ...

Latest FOMC statement highlights the possibility of softer US growth, but with strong labor markets and rising inflation, the ...

However, the business said on Thursday (July 31) the sale process had ended without a suitable offer being received. As a ...

SINGAPORE] Asia-Pacific could be the new frontier for biotechnology investment, a report by consulting firm Bain & Company ...